| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 30.644 | 51.447 | 72.085 | 36.990 | 48.542 | 62.665 | 65.796 | 42.452 | 29.675 | 24.958 |
| Total Income - EUR | 30.645 | 51.448 | 72.107 | 37.076 | 48.565 | 62.725 | 65.851 | 42.453 | 29.685 | 25.911 |
| Total Expenses - EUR | 24.351 | 16.492 | 57.036 | 34.746 | 73.627 | 74.977 | 60.937 | 53.180 | 25.003 | 44.432 |
| Gross Profit/Loss - EUR | 6.294 | 34.955 | 15.071 | 2.330 | -25.062 | -12.252 | 4.914 | -10.727 | 4.683 | -18.521 |
| Net Profit/Loss - EUR | 5.374 | 33.412 | 13.778 | 1.959 | -25.547 | -12.878 | 4.256 | -11.151 | 4.017 | -19.127 |
| Employees | 0 | 0 | 0 | 5 | 5 | 5 | 3 | 2 | 1 | 1 |
Check the financial reports for the company - Pharma Net Solutions Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 132 | 319 | 1.456 | 12.232 | 12.754 | 33.035 | 36.049 | 28.569 | 20.912 | 13.268 |
| Current Assets | 21.031 | 40.797 | 49.588 | 44.080 | 15.895 | 15.634 | 16.643 | 15.512 | 21.919 | 21.899 |
| Inventories | 0 | 0 | 0 | 488 | 478 | 469 | 459 | 460 | 459 | 456 |
| Receivables | 7.861 | 15.375 | 5.824 | 7.992 | 10.983 | 11.793 | 13.721 | 14.547 | 19.289 | 19.250 |
| Cash | 13.170 | 25.422 | 43.764 | 35.601 | 4.434 | 3.372 | 2.464 | 505 | 2.172 | 2.193 |
| Shareholders Funds | 8.387 | 36.396 | 17.115 | 5.244 | -20.405 | -32.896 | -27.911 | -39.149 | -35.013 | -53.945 |
| Social Capital | 403 | 399 | 786 | 771 | 757 | 742 | 726 | 728 | 726 | 722 |
| Debts | 12.776 | 4.721 | 33.928 | 51.069 | 49.054 | 81.622 | 80.744 | 83.198 | 77.854 | 89.112 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7311 - 7311" | |||||||||
| CAEN Financial Year |
7311
|
|||||||||
Comments - Pharma Net Solutions Srl